These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24847905)

  • 1. Environmental and genetic risk factors for retinal angiomatous proliferation.
    Caramoy A; Ristau T; Lechanteur YT; Ersoy L; Müller S; Gelisken F; Hoyng CB; Kirchhof B; den Hollander AI; Fauser S
    Acta Ophthalmol; 2014 Dec; 92(8):745-8. PubMed ID: 24847905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Maguire MG; Ying GS; Jaffe GJ; Toth CA; Daniel E; Grunwald J; Martin DF; Hagstrom SA;
    JAMA Ophthalmol; 2016 Jun; 134(6):674-81. PubMed ID: 27099955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
    Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.
    Hayashi H; Yamashiro K; Gotoh N; Nakanishi H; Nakata I; Tsujikawa A; Otani A; Saito M; Iida T; Matsuo K; Tajima K; Yamada R; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5914-9. PubMed ID: 20574013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration.
    Lechanteur YT; van de Camp PL; Smailhodzic D; van de Ven JP; Buitendijk GH; Klaver CC; Groenewoud JM; den Hollander AI; Hoyng CB; Klevering BJ
    JAMA Ophthalmol; 2015 May; 133(5):533-41. PubMed ID: 25695752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M
    Int Ophthalmol; 2017 Dec; 37(6):1397-1409. PubMed ID: 28005184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in the SKIV2L gene in exudative age-related macular degeneration in the Japanese population.
    Yoneyama S; Sakurada Y; Mabuchi F; Sugiyama A; Kubota T; Iijima H
    Ophthalmic Genet; 2014 Sep; 35(3):151-5. PubMed ID: 24865191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
    Piermarocchi S; Miotto S; Colavito D; Leon A; Segato T
    Acta Ophthalmol; 2015 Sep; 93(6):e451-7. PubMed ID: 25402348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
    van de Ven JP; Smailhodzic D; Boon CJ; Fauser S; Groenewoud JM; Chong NV; Hoyng CB; Klevering BJ; den Hollander AI
    Mol Vis; 2012; 18():2271-8. PubMed ID: 22933840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration.
    Ueda-Arakawa N; Ooto S; Nakata I; Yamashiro K; Tsujikawa A; Oishi A; Yoshimura N
    Am J Ophthalmol; 2013 Feb; 155(2):260-269.e2. PubMed ID: 23111182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
    Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.
    Kato Y; Oguchi Y; Omori T; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Ishida Y; Machida T; Sekine H; Sekiryu T
    Ophthalmol Sci; 2022 Jun; 2(2):100167. PubMed ID: 36249678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of risk alleles in patients with age-related macular degeneration.
    Nielsen MK; Subhi Y; Molbech CR; Grønskov K; Sørensen TL
    Dan Med J; 2020 Mar; 67(3):. PubMed ID: 32138827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population.
    Tanaka K; Nakayama T; Yuzawa M; Wang Z; Kawamura A; Mori R; Nakashizuka H; Sato N; Mizutani Y
    Mol Vis; 2011; 17():2751-8. PubMed ID: 22065928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes.
    Leveziel N; Zerbib J; Richard F; Querques G; Morineau G; Fremeaux-Bacchi V; Coscas G; Soubrane G; Benlian P; Souied EH
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3090-4. PubMed ID: 18362109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Nazari R; Soheilian M
    Int Ophthalmol; 2019 Apr; 39(4):949-956. PubMed ID: 29423786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.